+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Childhood Absence Epilepsy Treatment Market - Global Forecast 2025-2030- Product Image
Childhood Absence Epilepsy Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Childhood Absence Epilepsy Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010834
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Childhood Absence Epilepsy Treatment Market is evolving rapidly, guided by innovation in pharmacological therapies, neuromodulation, and dietary support. Senior decision-makers in pharmaceuticals, medical devices, and healthcare policy will benefit from a comprehensive exploration of shifting clinical practices and operational dynamics.

Market Snapshot: Childhood Absence Epilepsy Treatment Market Growth and Dynamics

The Childhood Absence Epilepsy Treatment Market grew from USD 255.22 million in 2024 to USD 274.62 million in 2025. It is expected to continue growing at a CAGR of 7.46%, reaching USD 393.11 million by 2030. Market expansion is fuelled by ongoing drug development, increasing prevalence of pediatric epilepsy diagnosis, and rising clinical adoption of advanced therapies.

Scope & Segmentation

  • Treatment Types: Anti-seizure medications such as ethosuximide, lamotrigine, levetiracetam, and valproate; dietary therapies including the ketogenic diet and modified Atkins regimen; as well as neurostimulation techniques like deep brain and vagus nerve stimulation.
  • Drug Classes: Ethosuximide, lamotrigine, levetiracetam, and valproate.
  • End Users: Home care settings (caregiver managed, home nursing), hospitals (inpatient, outpatient), and specialty clinics (epilepsy monitoring units, pediatric neurology centers).
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacy networks.
  • Regional Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: AbbVie Inc., GlaxoSmithKline plc, UCB S.A., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Pfizer Inc., Johnson & Johnson, Novartis AG.

Key Takeaways: Strategic Insights for the Childhood Absence Epilepsy Treatment Market

  • Advanced anti-seizure medications and targeted neurostimulation solutions are shifting clinical protocols toward more personalized and tolerable patient pathways.
  • Market adoption of dietary therapy, including modified ketogenic regimens, reflects increased focus on metabolic-based solutions for drug-resistant cases.
  • Telemedicine and decentralized care models are enhancing continuity of care, enabling remote monitoring and caregiver engagement across geographies.
  • Regional differences, especially in procurement and regulatory approaches, demand adaptable market-entry and distribution strategies.
  • Collaboration between pharmaceutical, device, and nutrition providers is shaping integrated treatment ecosystems and driving cross-sector product innovation.
  • Building real-world evidence and investing in post-market surveillance will support long-term safety monitoring and payer confidence.

Tariff Impact: Navigating U.S. Policy Adjustments

Revised tariffs in the United States on pharmaceuticals and medical devices are prompting industry players to assess alternative sourcing and local manufacturing. These adjustments impact active ingredient procurement and create shifts in device lead times and import costs. Responsive supply chain management and proactive policy engagement remain necessary for uninterrupted therapy availability and sustainable pricing structures.

Methodology & Data Sources

This research is grounded in primary interviews with clinical experts, device engineers, dietitians, and advocacy leaders, enriched by analysis of peer-reviewed studies, regulatory filings, and health technology registries. Advanced assessment, including cross-segmentation and scenario modeling, ensures rigorous and reliable market insights.

Why This Report Matters: Senior Decision Maker Value

  • Informs strategic investments by highlighting market drivers, operational challenges, and regional growth opportunities.
  • Supports risk mitigation through in-depth analysis of therapy adoption, reimbursement trends, and supply chain risks.
  • Enables stakeholder collaboration by detailing multi-modal treatment strategies and segment-specific dynamics.

Conclusion

The ongoing evolution of childhood absence epilepsy treatment reflects a convergence of clinical, technological, and policy changes. Leaders seeking improved patient outcomes, operational efficiency, and regulatory readiness will find actionable insights within this focused, evidence-driven report.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of precision medicine approaches integrating genomic profiling in childhood absence epilepsy treatment
5.2. Development of long-acting antiepileptic drug formulations targeting improved compliance in pediatric patients
5.3. Adoption of real-world evidence studies to evaluate comparative efficacy and safety of absence epilepsy therapies
5.4. Integration of AI-powered EEG pattern recognition tools for early diagnosis and treatment optimization
5.5. Emergence of novel GABA receptor modulators addressing drug resistance in childhood absence epilepsy management
5.6. Increasing investment in pediatric neurology clinical trials focusing on cannabidiol and other cannabinoid derivatives
5.7. Growing collaboration between biotech firms and academic centers for pediatric absence epilepsy drug discovery
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Childhood Absence Epilepsy Treatment Market, by Treatment Type
8.1. Introduction
8.2. Anti-Seizure Medication
8.2.1. Ethosuximide
8.2.2. Lamotrigine
8.2.3. Levetiracetam
8.2.4. Valproate
8.3. Dietary Therapy
8.3.1. Ketogenic Diet
8.3.2. Modified Atkinson Regimen
8.4. Neurostimulation
8.4.1. Deep Brain Stimulation
8.4.2. Vagus Nerve Stimulation
9. Childhood Absence Epilepsy Treatment Market, by Drug Class
9.1. Introduction
9.2. Ethosuximide
9.3. Lamotrigine
9.4. Levetiracetam
9.5. Valproate
10. Childhood Absence Epilepsy Treatment Market, by End User
10.1. Introduction
10.2. Home Care Settings
10.2.1. Caregiver Managed
10.2.2. Home Nursing
10.3. Hospitals
10.3.1. Inpatient
10.3.2. Outpatient
10.4. Specialty Clinics
10.4.1. Epilepsy Monitoring Units
10.4.2. Pediatric Neurology Centers
11. Childhood Absence Epilepsy Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Americas Childhood Absence Epilepsy Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Childhood Absence Epilepsy Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Childhood Absence Epilepsy Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. GlaxoSmithKline plc
15.3.3. UCB S.A.
15.3.4. Sanofi S.A.
15.3.5. Sun Pharmaceutical Industries Ltd.
15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.7. Viatris Inc.
15.3.8. Pfizer Inc.
15.3.9. Johnson & Johnson
15.3.10. Novartis AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET: RESEARCHAI
FIGURE 24. CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ETHOSUXIMIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ETHOSUXIMIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY LEVETIRACETAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY LEVETIRACETAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY VALPROATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY VALPROATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY KETOGENIC DIET, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY KETOGENIC DIET, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY MODIFIED ATKINSON REGIMEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY MODIFIED ATKINSON REGIMEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ETHOSUXIMIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ETHOSUXIMIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY LEVETIRACETAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY LEVETIRACETAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY VALPROATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY VALPROATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY CAREGIVER MANAGED, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY CAREGIVER MANAGED, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME NURSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME NURSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY EPILEPSY MONITORING UNITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY EPILEPSY MONITORING UNITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY PEDIATRIC NEUROLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY PEDIATRIC NEUROLOGY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 132. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 133. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 140. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 141. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 142. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 143. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 144. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 145. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 262. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 264. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 265. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. GERMANY CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 271. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2018-2024 (USD MILLION)
TABLE 272. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY ANTI-SEIZURE MEDICATION, 2025-2030 (USD MILLION)
TABLE 273. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2018-2024 (USD MILLION)
TABLE 274. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DIETARY THERAPY, 2025-2030 (USD MILLION)
TABLE 275. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 282. FRANCE CHILDHOOD ABSENCE EPILEPSY TREATMENT MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

  • AbbVie Inc.
  • GlaxoSmithKline plc
  • UCB S.A.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 274.62 Million
Forecasted Market Value ( USD ) by 2030 $ 393.11 Million
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Epilepsy Treatment Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Epilepsy Treatment Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 140 Pages
  • Global
From
Refractory Epilepsy Treatment Market - A Global and Regional Analysis: Focus on Treatment Type, Patient Type, Seizure Type, Distribution Channel, and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Refractory Epilepsy Treatment Market - A Global and Regional Analysis: Focus on Treatment Type, Patient Type, Seizure Type, Distribution Channel, and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • 147 Pages
  • Global
From
Epilepsy Treatment - Global Strategic Business Report - Product Image

Epilepsy Treatment - Global Strategic Business Report

  • Report
  • 483 Pages
  • Global
From
Epilepsy Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Epilepsy Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 173 Pages
  • Global
From
Levetiracetam Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Levetiracetam Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.